Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-04-28 Annual Report
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
PRTC Final Results & Publication of Annual Report
Annual Report Classification · 100% confidence The document is explicitly titled 'PureTech Health plc Annual Report and Accounts 2022'. It contains comprehensive sections including the Strategic Report, Financial Statements, Independent Auditor’s Report, Directors’ Report, and Remuneration Report. It covers the full fiscal year 2022 and provides detailed financial data, making it a standard Annual Report. FY 2022
2023-04-28 English
PRTC Final Results & Publication of Annual Report
Report Publication Announcement Classification · 95% confidence The document is an announcement from PureTech Health PLC regarding the release of its annual results and the filing of its Annual Report and Notice of AGM. While it contains financial highlights, it explicitly states that these are 'select highlights' and directs readers to the full Annual Report and Accounts available on the National Storage Mechanism. According to the 'Menu vs Meal' rule, this document serves as a notification of the publication of reports rather than the full report itself, making it a Report Publication Announcement (RPA). FY 2022
2023-04-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction data (Date, Volume, Price) and updates the total number of shares in treasury and in issue. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number suggests it is a regulatory announcement, but the content is specifically about share repurchase, making POS the most accurate classification over the general RNS fallback.
2023-04-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject matter in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (26 April 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares report, which maps to the filing code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number (6201X) confirms it is a regulatory announcement, but the content is specific enough to use the more precise code.
2023-04-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "PureTech Health PLC ... Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (25 April 2023), including volume, highest, lowest, and VWAP prices. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate filing code is POS.
2023-04-26 English
Vedanta Gets $106M+ to Advance Microbiome Pipeline
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (2966X) and the date stamp (25 April 2023), indicating it is a regulatory news service announcement. The content details PureTech Health plc noting an announcement from its Founded Entity, Vedanta Biosciences, regarding raising $106.5 Million in financing and updates on clinical trials (Phase 3 for VE303, Phase 2 for VE202). This type of announcement, which is a press release distributed via RNS about a significant corporate event (financing/capital raise), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER) or a specific corporate action like a dividend or management change, but rather a general corporate update disseminated through the regulatory channel. Although it discusses financing (CAP), the primary function of this specific document, as presented through RNS, is a general regulatory disclosure/press release about an event concerning a subsidiary, making RNS the most appropriate classification given the available options for non-specific regulatory news.
2023-04-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.